Over the last four years, the funds have delivered consistent double-digit returns to investors who have allocated to this ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Tencent's Q4 2024 shows revenue and earnings growth, but challenges in gaming and AI raise concerns. Read here for key ...